Diabetes research and clinical practice
Apr 5, 2025
AIMS: To evaluate the acceptability, applicability, and cost-utility of AI-powered portable fundus cameras for diabetic retinopathy (DR) screening in Hong Kong, providing a viable alternative screening solution for resource-limited areas.
Diabetes research and clinical practice
Jan 30, 2025
AIMS: We evaluated the cost-effectiveness of artificial intelligence (AI)-based diabetic retinopathy (DR) screening in Japan. This evaluation compared the simultaneous introduction of AI in nationwide health checkups, namely "specific health check-up...
Diabetes research and clinical practice
Dec 19, 2024
AIMS: Automated retinal image analysis using Artificial Intelligence (AI) can detect diabetic retinopathy as accurately as human graders, but it is not yet licensed in the NHS Diabetic Eye Screening Programme (DESP) in England. This study aims to ass...
Diabetes research and clinical practice
Oct 19, 2024
AIMS: To develop a machine learning model for predicting rapid kidney function decline in people with type 2 diabetes (T2D) and chronic kidney disease (CKD) and to pinpoint key modifiable risk factors for targeted interventions.
Diabetes research and clinical practice
Jun 25, 2024
BACKGROUND: Type 2 diabetes mellitus (T2DM) is a growing chronic disease that can lead to disability and early death. This study aimed to establish a predictive model for the 10-year incidence of T2DM based on novel anthropometric indices.
Diabetes research and clinical practice
Dec 2, 2023
PURPOSE OF THE STUDY: Assessing the lower extremity arterial stenosis scores (LEASS) in patients with diabetic foot ulcer (DFU) is a challenging task that requires considerable time and efforts from physicians, and it may yield varying results. The p...
Diabetes research and clinical practice
Feb 27, 2021
AIMS: The effective identification of individuals with early dysglycemia status is key to reduce the incidence of type 2 diabetes. We develop and validate a novel zero-cost tool that significantly simplifies the screening of undiagnosed dysglycemia.